Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 2 (2005), Issue 9 (September)

1. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
   Mol Cell Biol, 25(18): 8108-25. [Abstract] [Full-text]
2. Chemotherapeutic gemcitabine doublets in pancreatic carcinoma.
   Semin Oncol, 32(4): S9-13. [Abstract] [Full-text]
3. Recent updates on the role of chemotherapy in pancreatic cancer.
   Semin Oncol, 32(4): S1-3. [Abstract] [Full-text]
4. Reduced expression of the E-cadherin gene and its aberrant DNA methylation in hamster pancreatic tumors.
   Biochem Biophys Res Commun, 336(1): 49-53. [Abstract] [Full-text]
5. Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells.
   Surgery, 138(2): 299-305. [Abstract] [Full-text]
6. Synergistic induction of the MUC4 mucin gene by interferon-gamma and retinoic acid in human pancreatic tumour cells involves a reprogramming of signalling pathways.
   Oncogene, 24(40): 6143-54. [Abstract] [Full-text]
7. Combination therapy with tumor-lysate pulsed dendritic cells and antiangiogenic drug TNP-470 for mouse pancreatic cancer.
   Int J Cancer, 117(3): 499-505. [Abstract] [Full-text]
8. CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials.
   Br J Cancer, 93(7): 740-3. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.